Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 36.80
+0.79 (2.19%)
Jul 31, 2026, 3:04 PM CST
Pharmaron Beijing Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,379 | 1,017 | 1,690 | 5,919 | 1,497 | 3,544 |
Short-Term Investments | - | 885.65 | 257.27 | 179.36 | 613.24 | 1,080 |
Trading Asset Securities | 597.95 | 714.07 | 1,115 | 621.98 | 745.36 | 1,555 |
Cash & Short-Term Investments | 2,977 | 2,617 | 3,062 | 6,720 | 2,856 | 6,178 |
Cash Growth | 11.16% | -14.54% | -54.43% | 135.30% | -53.77% | 60.37% |
Accounts Receivable | 3,169 | 3,188 | 2,871 | 2,636 | 2,214 | 1,424 |
Other Receivables | 96.91 | 58.2 | 126.89 | 80.98 | 71.16 | 92.43 |
Receivables | 3,266 | 3,246 | 2,998 | 2,717 | 2,286 | 1,516 |
Inventory | 1,694 | 1,472 | 1,117 | 1,013 | 1,041 | 680.04 |
Other Current Assets | 1,114 | 442.71 | 430.73 | 423.68 | 352.82 | 269.05 |
Total Current Assets | 9,051 | 7,778 | 7,608 | 10,874 | 6,536 | 8,644 |
Property, Plant & Equipment | 12,194 | 11,970 | 10,798 | 10,062 | 8,464 | 5,811 |
Long-Term Investments | 1,218 | 1,158 | 883.04 | 1,005 | 1,008 | 762.67 |
Goodwill | 3,535 | 3,586 | 2,761 | 2,781 | 2,688 | 2,096 |
Other Intangible Assets | 1,168 | 1,197 | 791 | 789.06 | 802.53 | 692.94 |
Long-Term Deferred Tax Assets | 289.63 | 262.91 | 192.68 | 153.22 | 58.79 | 15.6 |
Long-Term Deferred Charges | 590.9 | 617.99 | 678.5 | 520.47 | 496.38 | 171.6 |
Other Long-Term Assets | 514.52 | 465.28 | 155.44 | 267.09 | 438.91 | 195.99 |
Total Assets | 28,562 | 27,094 | 23,927 | 26,477 | 20,493 | 18,389 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 628.25 | 606.59 | 477.09 | 412.22 | 406.35 | 315.53 |
Accrued Expenses | 948.03 | 1,050 | 853.93 | 805.65 | 784.92 | 626.21 |
Short-Term Debt | 1,197 | 1,265 | 764.97 | 577.07 | 662.77 | 421.76 |
Current Portion of Long-Term Debt | 3,664 | 3,501 | 282.34 | 150.34 | 74.94 | 60.54 |
Current Portion of Leases | - | 122.7 | 149.51 | 185.32 | 164.03 | 95.29 |
Current Income Taxes Payable | 242.36 | 133.2 | 160.08 | 184.55 | 145.87 | 81.34 |
Current Unearned Revenue | 1,004 | 960.61 | 834.86 | 740.87 | 832.14 | 679.62 |
Other Current Liabilities | 687.19 | 724.9 | 701.23 | 598.47 | 841.4 | 701.7 |
Total Current Liabilities | 8,370 | 8,364 | 4,224 | 3,654 | 3,912 | 2,982 |
Long-Term Debt | 1,844 | 1,772 | 4,377 | 8,200 | 4,454 | 4,423 |
Long-Term Leases | 396.3 | 379.42 | 401.31 | 585.2 | 760.51 | 284.34 |
Long-Term Unearned Revenue | 434.93 | 442.86 | 409.98 | 391.71 | 152.38 | 149.44 |
Long-Term Deferred Tax Liabilities | 401.75 | 397.15 | 291.87 | 290.04 | 261.01 | 173.3 |
Other Long-Term Liabilities | - | - | - | 117.58 | 112.09 | 81.56 |
Total Liabilities | 11,447 | 11,355 | 9,705 | 13,239 | 9,653 | 8,094 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 1,837 | 1,779 | 1,778 | 1,787 | 1,191 | 794.18 |
Additional Paid-In Capital | 6,079 | 4,950 | 5,008 | 5,222 | 5,254 | 6,008 |
Retained Earnings | 8,904 | 8,568 | 7,257 | 5,818 | 4,574 | 3,554 |
Treasury Stock | -304.89 | -304.89 | -416.27 | -463.45 | -668.04 | -301.83 |
Comprehensive Income & Other | -56.1 | 71.8 | -7.76 | 193.72 | 197.26 | 74.15 |
Total Common Equity | 16,458 | 15,064 | 13,619 | 12,557 | 10,549 | 10,129 |
Minority Interest | 656.16 | 674.38 | 603.54 | 681.25 | 291.25 | 166.07 |
Shareholders' Equity | 17,115 | 15,739 | 14,223 | 13,238 | 10,840 | 10,295 |
Total Liabilities & Equity | 28,562 | 27,094 | 23,927 | 26,477 | 20,493 | 18,389 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 7,101 | 7,040 | 5,975 | 9,698 | 6,117 | 5,285 |
Net Cash (Debt) | -4,124 | -4,423 | -2,913 | -2,977 | -3,260 | 893.04 |
Net Cash Growth | - | - | - | - | - | -68.12% |
Net Cash Per Share | -2.31 | -2.50 | -1.64 | -1.68 | -1.84 | 0.49 |
Filing Date Shares Outstanding | 1,830 | 1,830 | 1,766 | 1,787 | 1,787 | 1,787 |
Total Common Shares Outstanding | 1,830 | 1,771 | 1,766 | 1,787 | 1,787 | 1,787 |
Working Capital | 680.2 | -585.84 | 3,384 | 7,220 | 2,624 | 5,662 |
Book Value Per Share | 8.99 | 8.51 | 7.71 | 7.03 | 5.90 | 5.67 |
Tangible Book Value | 11,755 | 10,282 | 10,068 | 8,987 | 7,058 | 7,340 |
Tangible Book Value Per Share | 6.42 | 5.81 | 5.70 | 5.03 | 3.95 | 4.11 |
Buildings | - | 5,647 | 4,921 | 3,971 | 3,347 | 2,473 |
Machinery | - | 7,595 | 6,274 | 5,149 | 4,265 | 2,919 |
Construction In Progress | - | 2,365 | 2,254 | 2,633 | 1,671 | 1,374 |